
zzso peripheral blood zzso stem cells zzso are usually collected following zzso therapy accomplished by using growth factors zzso such as zzso or zzso with or without zzso A target dose of yielded zzso is usually prescribed by the attending physician depending on different zzso which may include single or double zzso zzso collection usually is performed when at least 20 zzso zzso are detected by means of flow zzso A cumulative dose of at least 2 zzso zzso zzso zzso has been considered as the threshold to allow a prompt and persistent zzso zzso Unfortunately, this goal is not achieved by the totality of patients undergoing zzso zzso In fact, zzso of patients who underwent zzso therapy fail zzso collection due to very low peripheral blood zzso zzso zzso zzso zzso including age, sex, stage of the underlying disease zzso or partial zzso diagnosis, previously administered zzso regimens, zzso from last chemotherapy before zzso and zzso schedule (including dose of zzso were considered as possibly zzso of poor or failed zzso We performed a retrospective analysis in zzso patients from three large Italian academic institutions to assess the zzso of poor zzso within our patients' zzso zzso a patient who fails a first zzso (and when an zzso related on unrelated donor is not zzso could undergo a second attempt either with different zzso schedule or by using different zzso such as stem cell factor, growth hormone zzso or more recently newly introduced drugs such as zzso alone or in combination with zzso or zzso Thus, we investigated the fate of those who failed a first zzso and subsequently underwent a second attempt or alternative therapeutic zzso 

